PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid AMOSKOWITZ, Samuel M; ERNST, Robert K; MILLER, Samuel I et al.Journal of bacteriology. 2004, Vol 186, Num 2, pp 575-579, issn 0021-9193, 5 p.Article

Pandoraea bacteremia in a cystic fibrosis patient with associated systemic illnessJOHNSON, Lindsey N; HAN, Jin-Young; MOSKOWITZ, Samuel M et al.The Pediatric infectious disease journal. 2004, Vol 23, Num 9, pp 881-882, issn 0891-3668, 2 p.Article

Shifting Patterns of Inhaled Antibiotic Use in Cystic FibrosisMOSKOWITZ, Samuel M; SILVA, Stefanie J; MAYER-HAMBLETT, Nicole et al.Pediatric pulmonology. 2008, Vol 43, Num 9, pp 874-881, issn 8755-6863, 8 p.Article

Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosisMOSKOWITZ, Samuel M; FOSTER, Jessica M; EMERSON, Julia et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 5, pp 1915-1922, issn 0095-1137, 8 p.Article

Use of Pseudomonas biofilm susceptibilities to assign simulated antibiotic regimens for cystic fibrosis airway infectionMOSKOWITZ, Samuel M; FOSTER, Jessica M; EMERSON, Julia C et al.Journal of antimicrobial chemotherapy (Print). 2005, Vol 56, Num 5, pp 879-886, issn 0305-7453, 8 p.Article

Polymyxin Resistance of Pseudomonas aeruginosa phoQ Mutants Is Dependent on Additional Two-Component Regulatory SystemsGUTU, Alina D; SGAMBATI, Nicole; STRASBOURGER, Pnina et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 5, pp 2204-2215, issn 0066-4804, 12 p.Article

Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosisERNST, Robert K; MOSKOWITZ, Samuel M; EMERSON, Julia C et al.The Journal of infectious diseases. 2007, Vol 196, Num 7, pp 1088-1092, issn 0022-1899, 5 p.Article

The Pseudomonas aeruginosa lipid a deacylase : Selection for expression and loss within the cystic fibrosis airwayERNST, Robert K; ADAMS, Kristin N; MOSKOWITZ, Samuel M et al.Journal of bacteriology. 2006, Vol 188, Num 1, pp 191-201, issn 0021-9193, 11 p.Article

PmrB Mutations Promote Polymyxin Resistance of Pseudomonas aeruginosa Isolated from Colistin-Treated Cystic Fibrosis PatientsMOSKOWITZ, Samuel M; BRANNON, Mark K; JOHANSEN, Helle K et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 2, pp 1019-1030, issn 0066-4804, 12 p.Article

Randomized Trial of Biofilm Testing to Select Antibiotics for Cystic Fibrosis Airway InfectionMOSKOWITZ, Samuel M; EMERSON, Julia C; GIBSON, Ronald L et al.Pediatric pulmonology. 2011, Vol 46, Num 2, pp 184-192, issn 8755-6863, 9 p.Article

PhoQ Mutations Promote Lipid A Modification and Polymyxin Resistance of Pseudomonas aeruginosa Found in Colistin-Treated Cystic Fibrosis PatientsMILLER, Amanda K; BRANNON, Mark K; STEVENS, Laurel et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 12, pp 5761-5769, issn 0066-4804, 9 p.Article

Colistin susceptibility testing: evaluation of reliability for cystic fibrosis isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophiliaMOSKOWITZ, Samuel M; GARBER, Elizabeth; CHEN, Yunhua et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 7, pp 1416-1423, issn 0305-7453, 8 p.Article